Pancoast tumor epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Pancoast tumor}}
{{Pancoast tumor}}
{{CMG}}{{AE}}{{Mazia}}
{{CMG}}; {{AE}} {{Mazia}}
==Overveiw==
==Overveiw==
Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers. In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000. The prevalence of lung cancer significantly increases among smokers and individuals with chronic exposure to risk factors for lung cancer. In 2014 the incidence of Pancoast tumor was approximately 3 cases per 100,000. Lung cancer is more common in older adults. It is rare in people under age 45. Males are thought to be more predisposed to the development of lung cancer. This gender discrepancy is often attributed to the historically increased rate of smoking among males compared to females. The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1. There is no racial predilection for Pancoast tumor. The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates. Western Europe and the U.S. have the highest incidence of lung cancer.
Pancoast tumors are a rare type of [[Non-small cell lung cancer|non-small cell lung cancers]] ([[NSCLC]]), account for fewer than 5% of all [[lung]] [[cancers]]. In the United States, the age-adjusted [[prevalence]] of pancoast tumor is estimated to be 5 per 100,000. In 2014, the [[incidence]] of Pancoast tumor was approximately 3 per 100,000 individuals. It is [[rare]] in people under age 45. [[Males]] are thought to be more predisposed to the [[development]] of [[lung cancer]]. The [[male]] to [[female]] [[ratio]] for the [[incidence]] of [[lung]] [[cancer]] is approximately 1.4 to 1. There is no [[racial]] predilection for Pancoast tumor. The [[incidence]] of [[lung]] [[cancer]] is lower in developing countries than in developed countries. Western Europe and the U.S. have the highest [[incidence]] of [[lung]] [[cancer]].
==Epidemiology and Demographics==
==Epidemiology and Demographics==
Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers.<ref name=SEER>Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref><ref name="SiegelMa2014">{{cite journal|last1=Siegel|first1=Rebecca|last2=Ma|first2=Jiemin|last3=Zou|first3=Zhaohui|last4=Jemal|first4=Ahmedin|title=Cancer statistics, 2014|journal=CA: A Cancer Journal for Clinicians|volume=64|issue=1|year=2014|pages=9–29|issn=00079235|doi=10.3322/caac.21208}}</ref><ref name=SEER>Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref><ref>{{cite web | title =Gender in lung cancer and smoking research | publisher =World Health Organization | date =2004 | url =http://www.who.int/gender/documents/en/lungcancerlow.pdf| format = PDF | accessdate =2007-05-26 }}</ref><ref name="pmid8010786">{{cite journal |vauthors=Ginsberg RJ, Martini N, Zaman M, Armstrong JG, Bains MS, Burt ME, McCormack PM, Rusch VW, Harrison LB |title=Influence of surgical resection and brachytherapy in the management of superior sulcus tumor |journal=Ann. Thorac. Surg. |volume=57 |issue=6 |pages=1440–5 |date=June 1994 |pmid=8010786 |doi= |url= |author=}}</ref><ref name="pmid9189936">{{cite journal |vauthors=Johnson DE, Goldberg M |title=Management of carcinoma of the superior pulmonary sulcus |journal=Oncology (Williston Park, N.Y.) |volume=11 |issue=6 |pages=781–5; discussion 785–6 |date=June 1997 |pmid=9189936 |doi= |url= |author=}}</ref>
Pancoast tumors are a [[rare]] type of [[Non-small cell lung cancer|non-small cell lung cancers]] ([[NSCLC]]), account for fewer than 5% of all [[lung]] [[cancers]].<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref><ref name="SiegelMa2014">{{cite journal|last1=Siegel|first1=Rebecca|last2=Ma|first2=Jiemin|last3=Zou|first3=Zhaohui|last4=Jemal|first4=Ahmedin|title=Cancer statistics, 2014|journal=CA: A Cancer Journal for Clinicians|volume=64|issue=1|year=2014|pages=9–29|issn=00079235|doi=10.3322/caac.21208}}</ref>
===Prevalence===
===Prevalence===
*In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000.
*In the United States, the age-adjusted [[prevalence]] of pancoast tumor is estimated to be 5 per 100,000 individuals.<ref name="pmid8010786">{{cite journal |vauthors=Ginsberg RJ, Martini N, Zaman M, Armstrong JG, Bains MS, Burt ME, McCormack PM, Rusch VW, Harrison LB |title=Influence of surgical resection and brachytherapy in the management of superior sulcus tumor |journal=Ann. Thorac. Surg. |volume=57 |issue=6 |pages=1440–5 |date=June 1994 |pmid=8010786 |doi= |url= |author=}}</ref><ref name=":0">{{cite web | title =Gender in lung cancer and smoking research | publisher =World Health Organization | date =2004 | url =http://www.who.int/gender/documents/en/lungcancerlow.pdf| format = PDF | accessdate =2007-05-26 }}</ref>
*The prevalence of lung cancer significantly increases among smokers and individuals with chronic exposure to risk factors for lung cancer.
*The [[prevalence]] of [[lung]] [[cancer]] significantly increases among [[Smoker's cough|smokers]] and individuals with [[chronic]] exposure to [[risk factors]] for [[lung cancer]].


===Incidence===
===Incidence===
*In 2014 the incidence of Pancoast tumor was approximately 3 cases per 100,000.
*In 2014, the [[incidence]] of Pancoast tumor was approximately 3 per 100,000 individuals.<ref name="pmid8010786" /><ref name=":0" />
*According to the American Cancer Society, an estimated 3,000 nonsmoking adults will die each year from lung cancer related to breathing secondhand smoke.
*According to the American Cancer Society, an estimated 3,000 nonsmoking [[Adult|adults]] will die each year from [[lung cancer]] related to [[breathing]] secondhand [[smoke]].
*Each year more people die of lung cancer than breast, colon, and prostate cancers combined.
*Each year more people die of [[lung cancer]] than [[breast]], [[colon]], and [[prostate]] [[cancers]] combined.
*It is unclear whether the increased incidence of lung cancer is due to increased cancers or improved cancer detection (e.g. screening techniques)
*It is unclear whether the increased [[incidence]] of [[lung cancer]] is due to increased [[cancers]] or improved [[cancer]] detection (e.g. [[Screening (medicine)|screening]] techniques).


===Age===
===Age===
*Lung cancer is more common in older adults. It is rare in people under age 45.  
*[[Lung cancer]] is more common in older people. It is rare in people under age 45.<ref name="pmid9189936">{{cite journal |vauthors=Johnson DE, Goldberg M |title=Management of carcinoma of the superior pulmonary sulcus |journal=Oncology (Williston Park, N.Y.) |volume=11 |issue=6 |pages=781–5; discussion 785–6 |date=June 1997 |pmid=9189936 |doi= |url= |author=}}</ref>


===Gender===
===Gender===
*Males are thought to be more predisposed to the development of lung cancer. This gender discrepancy is often attributed to the historically increased rate of smoking among males compared to females.
*[[Males]] are thought to be more predisposed to the development of [[lung cancer]]. This gender discrepancy is often attributed to the historically increased [[rate]] of [[smoking]] among [[males]] compared to [[females]].<ref name=":0" />
*The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1.
*The [[male]] to [[female]] [[ratio]] for the [[incidence]] of [[lung]] [[cancer]] is approximately 1.4 to 1.


===Race===
===Race===
*There is no racial predilection for Pancoast tumor.
*There is no [[racial]] predilection for Pancoast tumor.<ref name=":0" />
===Developing Countries===
===Developing Countries===
*The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates.
*The [[incidence]] of [[lung cancer]] is lower in developing countries than in developed countries. It is unknown whether this decreased [[incidence]] is due to decreased [[cancer]] rates or decreased detection rates.<ref name="pmid9189936" />
===Developed Countries===
===Developed Countries===
*Western Europe and the U.S. have the highest incidence of lung cancer.
*Western Europe and the U.S. have the highest [[incidence]] of [[lung cancer]].<ref name="pmid8010786" />


==References==
==References==

Latest revision as of 20:51, 27 March 2018


Pancoast tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pancoast tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pancoast tumor epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pancoast tumor epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pancoast tumor epidemiology and demographics

CDC onPancoast tumor epidemiology and demographics

Pancoast tumor epidemiology and demographics in the news

Blogs on Pancoast tumor epidemiology and demographics

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pancoast tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overveiw

Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers. In the United States, the age-adjusted prevalence of pancoast tumor is estimated to be 5 per 100,000. In 2014, the incidence of Pancoast tumor was approximately 3 per 100,000 individuals. It is rare in people under age 45. Males are thought to be more predisposed to the development of lung cancer. The male to female ratio for the incidence of lung cancer is approximately 1.4 to 1. There is no racial predilection for Pancoast tumor. The incidence of lung cancer is lower in developing countries than in developed countries. Western Europe and the U.S. have the highest incidence of lung cancer.

Epidemiology and Demographics

Pancoast tumors are a rare type of non-small cell lung cancers (NSCLC), account for fewer than 5% of all lung cancers.[1][2]

Prevalence

Incidence

Age

  • Lung cancer is more common in older people. It is rare in people under age 45.[5]

Gender

Race

  • There is no racial predilection for Pancoast tumor.[4]

Developing Countries

  • The incidence of lung cancer is lower in developing countries than in developed countries. It is unknown whether this decreased incidence is due to decreased cancer rates or decreased detection rates.[5]

Developed Countries

References

  1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  2. Siegel, Rebecca; Ma, Jiemin; Zou, Zhaohui; Jemal, Ahmedin (2014). "Cancer statistics, 2014". CA: A Cancer Journal for Clinicians. 64 (1): 9–29. doi:10.3322/caac.21208. ISSN 0007-9235.
  3. 3.0 3.1 3.2 Ginsberg RJ, Martini N, Zaman M, Armstrong JG, Bains MS, Burt ME, McCormack PM, Rusch VW, Harrison LB (June 1994). "Influence of surgical resection and brachytherapy in the management of superior sulcus tumor". Ann. Thorac. Surg. 57 (6): 1440–5. PMID 8010786.
  4. 4.0 4.1 4.2 4.3 "Gender in lung cancer and smoking research" (PDF). World Health Organization. 2004. Retrieved 2007-05-26.
  5. 5.0 5.1 Johnson DE, Goldberg M (June 1997). "Management of carcinoma of the superior pulmonary sulcus". Oncology (Williston Park, N.Y.). 11 (6): 781–5, discussion 785–6. PMID 9189936.

Template:WH Template:WS